Probable Role of Non-exosomal Extracellular Vesicles in Colorectal Cancer Metastasis to Kidney: An In Vitro Cell Line Based Study and Image Analysis

ICTMI 2017 ◽  
2019 ◽  
pp. 163-174
Author(s):  
Aviral Kumar ◽  
Reetoja Nag ◽  
Satyakam Mishra ◽  
Bandaru Ramakrishna ◽  
V. V. R. Sai ◽  
...  
Author(s):  
Aparna S. Narayan ◽  
Jayshree Nellore ◽  
Valli C. Nachiyar ◽  
Sujatha Peela

2018 ◽  
Vol 9 (6) ◽  
Author(s):  
Lin-Lin Ren ◽  
Ting-Ting Yan ◽  
Chao-Qin Shen ◽  
Jia-Yin Tang ◽  
Xuan Kong ◽  
...  

2016 ◽  
Author(s):  
Xin Zhang ◽  
Ryan Sullivan ◽  
Nathan Hite ◽  
Grace Maresh ◽  
Linh Hellmers ◽  
...  

2016 ◽  
Vol 15s4 ◽  
pp. CIN.S40301
Author(s):  
Nguyen Phuoc Long ◽  
Wun Jun Lee ◽  
Nguyen Truong Huy ◽  
Seul Ji Lee ◽  
Jeong Hill Park ◽  
...  

Colorectal cancer (CRC) is one of the most common and lethal cancers. Although numerous studies have evaluated potential biomarkers for early diagnosis, current biomarkers have failed to reach an acceptable level of accuracy for distant metastasis. In this paper, we performed a gene set meta-analysis of in vitro microarray studies and combined the results from this study with previously published proteomic data to validate and suggest prognostic candidates for CRC metastasis. Two microarray data sets included found 21 significant genes. Of these significant genes, ALDOA, IL8 (CXCL8), and PARP4 had strong potential as prognostic candidates. LAMB2, MCM7, CXCL23A, SERPINA3, ABCA3, ALDH3A2, and POLR2I also have potential. Other candidates were more controversial, possibly because of the biologic heterogeneity of tumor cells, which is a major obstacle to predicting metastasis. In conclusion, we demonstrated a meta-analysis approach and successfully suggested ten biomarker candidates for future investigation.


2019 ◽  
Vol 122 (4) ◽  
pp. 578-589
Author(s):  
Liang Wu ◽  
Zili Zhou ◽  
Shengbo Han ◽  
Jinhuang Chen ◽  
Zhengyi Liu ◽  
...  

Abstract Background We previously demonstrated that the pleomorphic adenoma gene like-2 (PLAGL2) is involved in the pathogenesis of Hirschsprung disease. Enhanced PLAGL2 expression was observed in several malignant tumours. However, the exact function of PLAGL2 and its underlying mechanism in colorectal cancer (CRC) remain largely unknown. Methods Immunohistochemical analysis of PLAGL2 was performed. A series of in vitro and in vivo experiments were conducted to reveal the role of PLAGL2 in the progression of CRC. Results Enhanced PLAGL2 expression was significantly associated with EMT-related proteins in CRC. The data revealed that PLAGL2 promotes CRC cell proliferation, migration, invasion and EMT both in vitro and in vivo. Mechanistically, PLAGL2 promoted the expression of ZEB1. PLAGL2 enhanced the expression and nuclear translocation of β-catenin by decreasing its phosphorylation. The depletion of β-catenin neutralised the regulation of ZEB1 that was caused by enhanced PLAGL2 expression. The small-molecule inhibitor PNU-74654, also impaired the enhancement of ZEB1 that resulted from the modified PLAGL2 expression. The depletion of ZEB1 could block the biological function of PLAGL2 in CRC cells. Conclusions Collectively, our findings suggest that PLAGL2 mediates EMT to promote colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1.


Oncogene ◽  
2017 ◽  
Vol 36 (22) ◽  
pp. 3104-3118 ◽  
Author(s):  
E Agarwal ◽  
C M Robb ◽  
L M Smith ◽  
M G Brattain ◽  
J Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document